<DOC>
	<DOCNO>NCT00436839</DOCNO>
	<brief_summary>To compare overall survival receive mitoxantrone prednisone docetaxel prednisone subject hormone-refractory metastatic prostate cancer .</brief_summary>
	<brief_title>Taxotere Prostate Cancer New Indication Registration Trial China</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<criteria>Histologically cytologically proven prostate adenocarcinoma Androgen independent prostate Cancer S/P orchiectomy and/or LHRH agonist Testosterone &lt; 50 ng/dl ( ie 1.735 nmol/l ) Documented progressive disease Patients achieve stable analgesia 7 day Karnofsky Performance Status ≥ 70 No prior treatment cytotoxic agent ( except estramustine ) Normal cardiac function must confirm Left ventricular ejection fraction Adequate organ function : 1 . Hematology : Neutrophils &gt; 1.5 x 10^9/L Hemoglobin &gt; 10 g/dl . Erythropoietin use allow , red blood cell transfusion upgrade hemoglobin level allow Platelets &gt; 100 x 10^9/L 2 . Hepatic function : Total bilirubin &lt; uppernormal limit institution . Alanine aminotransferase Aspartate transaminase &lt; 1.5 time uppernormal limit institution . 3 . Renal function : Creatinine &lt; 1.5 time upper normal limit ( ie National Cancer Institution grade &lt; 1 ) No brain leptomeningeal metastases Prior radiotherapy &gt; 25 % bone marrow ( whole pelvic irradiation allow ) prior cytotoxic chemotherapy , except monotherapy estramustine prior isotope therapy history another cancer within precede five year symptomatic peripheral neuropathy grade ≥ 2 serious illness medical condition : 1 . Congestive heart failure even control . Previous history myocardial infarction angina pectoris within 1 year study entry , uncontrolled hypertension uncontrolled arrhythmias . 2 . Active uncontrolled infection 3 . Peptic ulcer , unstable diabetes mellitus contraindication use corticosteroid . 4 . Autoimmune disease ( lupus , sclerodermia , rheumatoid polyarthritis ) treatment anticancer therapy treatment bisphosphonates The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>